Clinical trials: Orthopedic Procedures, Tranexamic Acid, open to volunteers
Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System
Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma
Tranexamic acid, an anti-fibrinolytic agent, is commonly given after induction of general anesthesia in patients undergoing hip and knee arthroplasty.
- Trial name
- TXA (NCT07116395)
- Testing
- Tranexamic Acid (TXA)
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Arbi Nazarian, MD